Babcock & Wilcox Enterprises, Inc Management’s Discussion And Analysis Of Financial Condition And Resultsof Operations Form Ten-q
Discovery of ketone-based covalent inhibitors of coronavirus 3CL proteases for the prospective therapeutic remedy of COVID-19. 63, 12725–12747 . Structural, electronic, and electrostatic determinants for inhibitor binding to subsites S1...
